T cell immunoglobulin-3 as a new therapeutic target for rheumatoid arthritis

Expert Opinion on Therapeutic Targets

Volumn 16, Issue 12, 2012, Pages 1145-1149

  Li, Xia ^a   Zhao, Yi Qing ^a   Li, Cheng Wan ^a   Yuan, Feng Lai ^a  

^a NANTONG UNIVERSITY   (China)

Author keywords

Autoimmune; Galectin 9; Rheumatoid arthritis; T cell immunoglobulin 3

Indexed keywords

ECALECTIN; GAMMA INTERFERON; IMMUNOGLOBULIN G3; T LYMPHOCYTE IMMUNOGLOBULIN 3; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; AUTOIMMUNE DISEASE; DISEASE SEVERITY; HUMAN; INTERFERON PRODUCTION; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REVIEW; RHEUMATOID ARTHRITIS; UPREGULATION;

ANIMALS; ARTHRITIS, RHEUMATOID; GALECTINS; HUMANS; MEMBRANE PROTEINS;

EID: 84869402582     PISSN: 14728222     EISSN: 17447631     Source Type: Journal    
DOI: 10.1517/14728222.2012.726616     Document Type: Review

References (35)

1. Wong JB, Ramey DR, Singh G. Long-term morbidity, mortality, and economics of rheumatoid arthritis. Arthritis Rheum 2001;44:2746-9
2. Lajas C, Abasolo L, Bellajdel B, et al. Costs and predictors of costs in rheumatoid arthritis: a prevalence-based study. Arthritis Rheum 2003;49:64-70
3. Dugowson CE, Koepsell TD, Voigt LF, et al. Rheumatoid arthritis in women. Incidence rates in group health cooperative, Seattle, Washington, 1987-1989. Arthritis Rheum 1991;34:1502-7
4. Li X, Yuan FL, Lu WG, et al. The role of interleukin-17 in mediating joint destruction in rheumatoid arthritis. Biochem Biophys Res Commun 2010;397:131-5
5. Yuan FL, Li X, Lu WG, et al. IL-33: a promising therapeutic target for rheumatoid arthritis? Expert Opin Ther Targets 2011;15:529-34
6. Monney L, Sabatos CA, Gaglia JL, et al. Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature 2002;415:536-41
7. Zhu C, Anderson AC, Kuchroo VK. TIM-3 and its regulatory role in immune responses. Curr Top Microbiol Immunol 2011;350:1-15
8. Chae SC, Park YR, Shim SC, et al. The polymorphisms of Th1 cell surface gene Tim-3 are associated in a Korean population with rheumatoid arthritis. Immunol Lett 2004;95:91-5
9. Xu J, Yang Y, Liu X, et al. The-1541 C > T and +4259 G > T of TIM-3 polymorphisms are associated with rheumatoid arthritis susceptibility in a Chinese Hui population. Int J Immunogenet 2011;38:513-18
10. Hastings WD, Anderson DE, Kassam N, et al. TIM-3 is expressed on activated human CD4+ T cells and regulates Th1 and Th17 cytokines. Eur J Immunol 2009;39:2492-501
11. Seki M, Oomizu S, Sakata KM, et al. Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis. Clin Immunol 2008;127:78-88
12. Lee J, Oh JM, Hwang JW, et al. Expression of human TIM-3 and its correlation with disease activity in rheumatoid arthritis. Scand J Rheumatol 2011;40:334-40
13. Lee J, Park EJ, Noh JW, et al. Underexpression of TIM-3 and blunted galectin-9-induced apoptosis of CD4+ T cells in rheumatoid arthritis. Inflammation 2012;35:633-7
14. Khademi M, Illes Z, Gielen AW, et al. T Cell Ig-and mucin-domain- containing molecule-3 (TIM-3) and TIM-1 molecules are differentially expressed on human Th1 and Th2 cells and in cerebrospinal fluid-derived mononuclear cells in multiple sclerosis. J Immunol 2004;172:7169-76
15. Anderson DE. TIM-3 as a therapeutic target in human inflammatory diseases. Expert Opin Ther Targets 2007;11:1005-9
16. Sabatos CA, Chakravarti S, Cha E, et al. Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral tolerance. Nat Immunol 2003;4:1102-10
17. Fukushima A, Sumi T, Fukuda K, et al. Antibodies to T-cell Ig and mucin domain-containing proteins (Tim)-1 and 3 suppress the induction and progression of murine allergic conjunctivitis. Biochem Biophys Res Commun 2007;353:211-16
18. Sanchez-Fueyo A, Tian J, Picarella D, et al. Tim-3 inhibits T helper type 1-mediated auto-and alloimmune responses and promotes immunological tolerance. Nat Immunol 2003;4:1093-101
19. Jones RB, Ndhlovu LC, Barbour JD, et al. Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection. J Exp Med 2008;205:2763-79
20. Boenisch O, D'Addio F, Watanabe T, et al. TIM-3: a novel regulatory molecule of alloimmune activation. J Immunol 2010;185:5806-19
21. Su EW, Lin JY, Kane LP. TIM-1 and TIM-3 proteins in immune regulation. Cytokine 2008;44:9-13
22. Anderson AC, Anderson DE, Bregoli L, et al. Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells. Science 2007;318:1141-3
23. Kuchroo VK, Dardalhon V, Xiao S, et al. New roles for TIM family members in immune regulation. Nat Rev Immunol 2008;8:577-80
24. Zhu C, Anderson AC, Schubart A, et al. The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat Immunol 2005;6:1245-52
25. Anderson AC, Anderson DE. TIM-3 in autoimmunity. Curr Opin Immunol 2006;18:665-9
26. Wada J, Kanwar YS. Identification and characterization of galectin-9, a novel beta-galactoside-binding mammalian lectin. J Biol Chem 1997;272:6078-86
27. Rodriguez-Manzanet R, DeKruyff R, Kuchroo VK, et al. The costimulatory role of TIM molecules. Immunol Rev 2009;229:259-70
28. Imaizumi T, Kumagai M, Sasaki N, et al. Interferon-gamma stimulates the expression of galectin-9 in cultured human endothelial cells. J Leukoc Biol 2002;72:486-91
29. Sakai K, Kawata E, Ashihara E, et al. Galectin-9 ameliorates acute GVH disease through the induction of T-cell apoptosis. Eur J Immunol 2011;41:67-75
30. Veenstra RG, Taylor PA, Zhou Q, et al. Contrasting acute graft-versus-host disease effects of Tim-3/galectin-9 pathway blockade dependent upon the presence of donor regulatory T cells. Blood 2012;120:682-90
31. Oomizu S, Arikawa T, Niki T, et al. Galectin-9 suppresses Th17 cell development in an IL-2-dependent but Tim-3-independent manner. Clin Immunol 2012;143:51-8
32. Pan HF, Zhang N, Li WX, et al. TIM-3 as a new therapeutic target in systemic lupus erythematosus. Mol Biol Rep 2010;37:395-8
33. Liu Y, Shu Q, Gao L, et al. Increased Tim-3 expression on peripheral lymphocytes from patients with rheumatoid arthritis negatively correlates with disease activity. Clin Immunol 2010;137:288-95
34. Seki M, Sakata KM, Oomizu S, et al. Beneficial effect of galectin 9 on rheumatoid arthritis by induction of apoptosis of synovial fibroblasts. Arthritis Rheum 2007;56:3968-76
35. Arikawa T, Watanabe K, Seki M, et al. Galectin-9 ameliorates immune complex-induced arthritis by regulating Fc gamma R expression on macrophages. Clin Immunol 2009;133:382-92